Eloxx Pharmaceuticals Statistics
Total Valuation
ELOX has a market cap or net worth of $48.62 million. The enterprise value is $54.08 million.
Important Dates
The last earnings date was Monday, November 13, 2023, after market close.
| Earnings Date | Nov 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ELOX has 4.04 million shares outstanding. The number of shares has increased by 908.65% in one year.
| Current Share Class | 4.04M |
| Shares Outstanding | 4.04M |
| Shares Change (YoY) | +908.65% |
| Shares Change (QoQ) | +1,166.84% |
| Owned by Insiders (%) | 3.88% |
| Owned by Institutions (%) | n/a |
| Float | 1.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 118.82% |
| Weighted Average Cost of Capital (WACC) | -743,117.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$804,000 |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,094,900.00% in the last 52 weeks. The beta is -167,970.40, so ELOX's price volatility has been lower than the market average.
| Beta (5Y) | -167,970.40 |
| 52-Week Price Change | +1,094,900.00% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 2.11 |
| Relative Strength Index (RSI) | 59.84 |
| Average Volume (20 Days) | 39,156 |
Short Selling Information
The latest short interest is 21,485, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 21,485 |
| Short Previous Month | 42,744 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 1.21% |
| Short Ratio (days to cover) | 1.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.01M |
| Pretax Income | -8.04M |
| Net Income | -8.04M |
| EBITDA | n/a |
| EBIT | -9.01M |
| Earnings Per Share (EPS) | -$3.77 |
Full Income StatementBalance Sheet
The company has $6.36 million in cash and $11.82 million in debt, giving a net cash position of -$5.46 million or -$1.35 per share.
| Cash & Cash Equivalents | 6.36M |
| Total Debt | 11.82M |
| Net Cash | -5.46M |
| Net Cash Per Share | -$1.35 |
| Equity (Book Value) | -7.58M |
| Book Value Per Share | -16.44 |
| Working Capital | -7.58M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.98M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 2.18M |
| Free Cash Flow | -12.98M |
| FCF Per Share | -$3.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |